Anthony J. Maddaluna, executive vice president and president of Pfizer Global Supply will retire after more than 41 years with the company. Kirsten Lund-Jurgensen will succeed Mr. Maddaluna, effective December 30, 2016. She is currently vice president, Innovative Health Product Portfolio Management and Consumer Operations. Ms. Lund-Jurgensen will report directly to Mr. Read and join Pfizer’s executive leadership team.
 
“I have had the privilege of working with Tony during much of his career, and he has been a valuable partner to me,” said Ian Read, chairman and chief executive officer, Pfizer. “Tony has continually demonstrated a steadfast commitment to Pfizer and our mission. His focus on quality, compliance and customer service has established Pfizer Global Supply as an industry leading supply organization that is highly respected by internal and external stakeholders. I know I join all Pfizer colleagues in thanking Tony for his tireless efforts and wishing him and his family all the best as he embarks on the next stage of his life.”

Mr. Maddaluna began his career at Pfizer in 1975 and has held several positions of increasing responsibility prior to being named president of Pfizer Global Supply in 2011.

“Kirsten has already been playing a leadership role in Pfizer Global Supply, and her wealth of knowledge, extensive operational experience and solid track record of delivering results make her an excellent choice for the leader of our supply organization,” said Mr. Read.

Ms. Lund-Jurgensen joined the company in 1999 as vice president, Global Supply Chain Management, Pharmaceuticals. Prior to Pfizer, she was with SmithKline Beecham in Germany, Australia, and the U.S., working in several operational roles.